ARDS
ARIDIS PHARMACEUTICAL INCstockOTC
EODNov 17, 2026
0.0001USD0.000%(0.00)900
ARDS News
ICU: QUELIMMUNE® Commercial Adoption Continues; Adult AKI Study Progresses Toward 2027 Completion ·
Zacks Small Cap Research
Edesa Biotech licenses ARDS drug to Kyorin for Japan market ·
Investing.com